NCT01890538

Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo

Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 94 (actual)
• Sponsor: Kocaeli University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study aims to investigate efficacy of two different intravenous drugs (dimenhydrinate and piracetam) in the symptomatic management of peripheral vertigo. The patients will be randomized in two groups according to symptomatic treatment modalities: Dimenhydrinate (100 mg) and piracetam (2 g) will be given in 100 cc normal saline in 30 minutes. Each patient will be asked if her/his vertigo symptoms resolved or not, according to a numeric rating scale (0=no vertigo, 10=worst possible vertigo). The patient will be rate the intensity of symptoms in the following times: * Numeric rating scale (1 to 10): Admission * Numeric rating scale (1 to 10): After the study drug (No ambulation)\* * Numeric rating scale (1 to 10): After the study drug (Ambulation)\* * Ambulation refers to head movements or walking in the room, if applicable.

Conditions

• Peripheral Vertigo

Interventions

Type	Name	Description
DRUG	Administration of 100 mg dimenhydrinate intravenous
DRUG	2 g piracetam intravenous

Timeline

• Start date: 2013-06-01
• Primary completion: 2014-05-01
• Completion: 2014-05-01
• First posted: 2013-07-01
• Last updated: 2014-05-05

Locations

1 site across 1 country: Turkey (Türkiye)